EUVIMEDEUVIMED entdecken
Crossref

Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease

Kosaku Nitta, Hiroshi Kataoka, Shun Manabe, Shiho Makabe, Taro Akihisa, Yusuke Ushio, Momoko Seki, Ken Tsuchiya, Junichi Hoshino, Toshio Mochizuki

Clinical and Experimental Nephrology · 2025

DOI: 10.1007/s10157-024-02568-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Nephrology, 2025. Verfasst von Kosaku Nitta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan. Hauptthemen laut MEDLINE: Hyperphosphatemia, Polycystic Kidney, Autosomal Dominant, Phosphates, Kidney. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Serum phosphate (P) levels are generally lower in autosomal dominant polycystic kidney disease (ADPKD) than in other kidney disorders, potentially masking the clinical significance of hyperphosphatemia. This study aimed to determine if serum P levels can predict renal outcomes in ADPKD patients. METHODS: We included 235 patients with ADPKD who were not taking drugs to treat hyperphosphatemia. Survival analysis was performed for the renal outcome of a 50% reduction in estimated glomerular filtration rate or initiation of renal replacement therapy. RESULTS: Multivariable Cox regression analyses revealed that serum P (1 mg/dL increase, HR = 2.03, P 3.5 mg/dL, HR = 2.05; P > 4.0 mg/dL, HR = 1.90; P > 4.5 mg/dL, HR = 2.78; P > 5.0 mg/dL, HR = 27.22) was significantly associated with renal prognosis. Kaplan-Meier analysis showed significantly lower kidney survival rates in patients with P > 3.5 mg/dL than in those without hyperphosphatemia (log-rank test, P 4.0 mg/dL, P > 4.5 mg/dL, and P > 5.0 mg/dL. The 2 year kidney survival rate for ADPKD patients with P > 3.5 mg/dL was 66.7% overall and 41.4% in those with stage 4-5 CKD. For patients with P > 4.0 mg/dL, the survival rate dropped to 46.8% overall and 28.2% in those with stage 4-5 CKD, indicating a very poor prognosis. CONCLUSION: Hyperphosphatemia was associated with renal prognosis in patients with ADPKD. In these patients, attention should be paid to even mild serum P elevation of > 3.5 or > 4.0 mg/dL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperphosphatemiaPolycystic Kidney, Autosomal DominantPhosphatesKidneyHumansMaleFemaleMiddle AgedAdultDisease ProgressionPrognosisGlomerular Filtration RateRisk FactorsRetrospective StudiesAgedRenal Replacement TherapyBiomarkers

Stichwörter der Autor:innen

Autosomal dominant polycystic kidney diseasePhosphateRenal prognosis

Substanzen

PhosphatesBiomarkers

Autor:innen und Institutionen

  • Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan.
  • Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan. kataoka@twmu.ac.jp.
  • Department of Blood Purification, Tokyo Women's Medical University, Tokyo, Japan.
  • PKD Nephrology Clinic, Tokyo, Japan.

Zitieren

APA

Nitta, K., Kataoka, H., Manabe, S., Makabe, S., Akihisa, T., Ushio, Y., Seki, M., Tsuchiya, K., Hoshino, J., & Mochizuki, T. (2025). Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease. Clinical and Experimental Nephrology. https://doi.org/10.1007/s10157-024-02568-6

Vancouver

Nitta K, Kataoka H, Manabe S, Makabe S, Akihisa T, Ushio Y, et al. Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease. Clinical and Experimental Nephrology. 2025. doi:10.1007/s10157-024-02568-6

BibTeX
@article{Nitta2025,
  author = {Nitta, Kosaku and Kataoka, Hiroshi and Manabe, Shun and Makabe, Shiho and Akihisa, Taro and Ushio, Yusuke and Seki, Momoko and Tsuchiya, Ken and Hoshino, Junichi and Mochizuki, Toshio},
  title = {Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney disease},
  journal = {Clinical and Experimental Nephrology},
  year = {2025},
  doi = {10.1007/s10157-024-02568-6}
}
Kostenlos starten →